Personalized CRT - MPP Post Approval Study
Personalized CRT - Multiple Point Pacing Post Approval Study
1 other identifier
observational
1,338
13 countries
78
Brief Summary
The purpose of this Post-Approval Study (PAS) is to evaluate the effectiveness of MPP to improve CRT response in the non-responder patient population when used in "real-world" clinical practice, following commercial release. This evaluation is based on the Clinical Composite Score which summarizes the proportions and frequencies of CRT non-responder patients who are "improved", "unchanged" or "worsened" after receiving MPP therapy. Patients will be followed for the duration of the PAS. This study is required by FDA as a condition of approval of the MPP feature and is integrated within the Product Surveillance Registry (PSR).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jul 2017
Typical duration for all trials
78 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 5, 2017
CompletedFirst Submitted
Initial submission to the registry
July 26, 2017
CompletedFirst Posted
Study publicly available on registry
July 28, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 4, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
January 7, 2021
CompletedFebruary 17, 2021
February 1, 2021
2.9 years
July 26, 2017
February 15, 2021
Conditions
Outcome Measures
Primary Outcomes (1)
MPP therapy responder
To estimate the proportion of MPP therapy responders among patients who did not respond to standard CRT and had MPP programmed "on".
Up to 3 years
Secondary Outcomes (1)
HF hospitalization and/or mortality
Up to 3 years
Study Arms (1)
CRT non-responders with MPP enabled
Patients enrolled and implanted with a CRT Quad system, who are identified as CRT non-responder, for which MPP is enabled.
Interventions
The multiple point pacing feature (MPP) is designed to allow pacing from 2 LV electrodes.
Eligibility Criteria
The study population includes patients that are or will be implanted with an eligible CRT Quad system.
You may qualify if:
- Patient or legally authorized representative provides written authorization and/or consent per institution and geographical requirements
- Patient has or is intended to receive or be treated with an eligible CRT device
- Patient within 30 days of therapy received at the time of their initial PSR platform enrollment
You may not qualify if:
- Patient who is, or is expected to be inaccessible for follow-up
- Patient is currently enrolled in or plans to enroll in any concurrent drug and/or device study that may confound results
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Medtroniclead
Study Sites (78)
University of Alabama at Birmingham
Birmingham, Alabama, 35294-0001, United States
Saint Vincent Heart Clinic Arkansas
Little Rock, Arkansas, 72205-6202, United States
Chula Vista Cardiac Center
Chula Vista, California, 91910, United States
Desert Heart Rhythm Consultants
Palm Springs, California, 92262, United States
COR Healthcare
Torrance, California, 90505, United States
Colorado Springs Cardiology
Colorado Springs, Colorado, 80907, United States
Denver Heart
Denver, Colorado, 80204, United States
Colorado Heart and Vascular, PC
Lakewood, Colorado, 80228, United States
Heart Rhythm Solutions
Hollywood, Florida, 33021, United States
Baptist Health
Jacksonville, Florida, 32207, United States
Heart & Vascular Institute of Florida
Safety Harbor, Florida, 34695-6604, United States
Phoebe Putney Memorial Hospital
Albany, Georgia, 31701, United States
The University of Kansas Medical Center
Kansas City, Kansas, 66160-8500, United States
MedStar Health Research Institute
Baltimore, Maryland, 21237-3958, United States
The Johns Hopkins Hospital
Bethesda, Maryland, 20817, United States
Delmarva Heart Research Foundation Inc
Salisbury, Maryland, 21804-6938, United States
Massachusetts General Hospital
Boston, Massachusetts, 02114-2621, United States
Brigham and Women's Hospital
Boston, Massachusetts, 02115, United States
UP Health System - Marquette
Marquette, Michigan, 49855-2705, United States
Michigan Heart
Ypsilanti, Michigan, 48197-8633, United States
Minneapolis Heart Institute Foundation
Minneapolis, Minnesota, 55407-1157, United States
North Memorial Heart and Vascular Institute
Robbinsdale, Minnesota, 55422, United States
Mayo Clinic
Rochester, Minnesota, 55905, United States
Missouri Cardiovascular Specialists
Columbia, Missouri, 65201-8023, United States
Washington University School of Medicine
St Louis, Missouri, 63110-1010, United States
HealthCare Partners Medical Group
Henderson, Nevada, 89052-4171, United States
Presbyterian Heart Group
Albuquerque, New Mexico, 87106-4921, United States
Island Cardiac Specialists
Garden City, New York, 11530-1613, United States
Huntington Hospital
Huntington, New York, 11743-2787, United States
Northwell Health
Manhasset, New York, 11030, United States
Hudson Valley Heart Center
Poughkeepsie, New York, 12601-3923, United States
Central New York Cardiology
Utica, New York, 13501-5930, United States
WakeMed Health & Hospitals
Raleigh, North Carolina, 27610, United States
Northeast Ohio Cardiovascular Specialists
Akron, Ohio, 44304-1473, United States
The Christ Hospital Health Network
Cincinnati, Ohio, 45219, United States
University of Cincinnati
Cincinnati, Ohio, 45267-0542, United States
Mercy Health - Saint Vincent Medical Center
Toledo, Ohio, 43608, United States
Cleveland Clinic
Cleveland, Oklahoma, 44195-0001, United States
Lehigh Valley Health Network
Allentown, Pennsylvania, 18103-6381, United States
Geisinger Medical Center
Danville, Pennsylvania, 17822, United States
Geisinger Wyoming Valley Medical Center
Wilkes-Barre, Pennsylvania, 18711, United States
Saint Thomas Research Institute
Nashville, Tennessee, 37205-2018, United States
Texas Cardiac Arrhythmia Research Foundation
Austin, Texas, 78705-1852, United States
The University of Vermont Medical Center
Burlington, Vermont, 05401, United States
Kootenai Heart Clinics Northwest
Spokane, Washington, 99204-2352, United States
Aurora Cardiovascular Services
Milwaukee, Wisconsin, 53215, United States
UZ Leuven - Campus Gasthuisberg
Leuven, 3000, Belgium
CHU UCL Mont-Godinne - Dinant
Yvoir, 5530, Belgium
Montreal Heart Institute
Montreal, Quebec, H1T 1C8, Canada
Institut de cardiologie et de pneumologie de Québec (IUCPQ)
Québec, Quebec, G1V 4G5, Canada
CHRU Brest - Hôpital de la Cavale Blanche
Brest, 29609, France
Centre Hospitalier Universitaire de Clermont-Ferrand - Gabriel-Montpied
Clermont-Ferrand, 63003, France
CHRU La Rochelle
La Rochelle, 17019, France
CHU de Montpellier - Hôpital Arnaud de Villeneuve
Montpellier, 34295, France
Nouvelles Cliniques Nantaises
Nantes, 44277, France
Centre hospitalier de la région d'Annecy
Pringy, 74374, France
Universitätsklinikum Aachen, AöR
Aachen, 52074, Germany
St. Vinzenz-Hospital Köln
Cologne, 50733, Germany
Universitätsklinikum Essen
Essen, 045147, Germany
Universitätsklinikum des Saarlandes
Homburg, 66421, Germany
Eberhard Karls Universität Tübingen - Universitätsklinikum Tübingen
Tübingen, 72076, Germany
Universitätsklinikum Ulm
Ulm, 89081, Germany
Magyar Honvédség Honvédkorház
Budapest, 1134, Hungary
Azienda Ospedaliera Ospedale Niguarda Cà Granda
Milan, 20162, Italy
Institut Jantung Negara - National Heart Institute
Kuala Lumpur, 50400, Malaysia
Maastricht Universitair Medisch Centrum
Maastricht, 6229 HX, Netherlands
Maasstad Hospital Rotterdam
Rotterdam, 3079 DZ, Netherlands
Vychodoslovensky ustav srdcovych a cievnych chorob, a.s.
Košice, 04011, Slovakia
Samsung Medical Center
Seoul, 135-710, South Korea
Hospital Universitario da Coruña
A Coruña, 15006, Spain
Hospital General Universitario Gregorio Maranon
Madrid, 28007, Spain
Hospital Universitario Son Espases
Palma de Mallorca, 07210, Spain
Complejo Hospitalario Universitario de Santiago de Compostela
Santiago de Compostela, 15706, Spain
University Hospitals of Birmingham NHS Foundation Trust - Queen Elizabeth Hospital
Birmingham, B15 2GW, United Kingdom
Glenfield Hospital
Leicester, LE3 9QP, United Kingdom
Liverpool Heart and Chest Hospital NHS Foundation Trust
Liverpool, L14 3PE, United Kingdom
Central Manchester University Hospitals NHS - Manchester Royal Infirmary
Manchester, M13 9WL, United Kingdom
The James Cook University Hospital - South Tees Hospitals NHS
Middlesbrough, TS4 3BW, United Kingdom
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Target Duration
- 3 Years
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 26, 2017
First Posted
July 28, 2017
Study Start
July 5, 2017
Primary Completion
June 4, 2020
Study Completion
January 7, 2021
Last Updated
February 17, 2021
Record last verified: 2021-02